Moore LM - Search Results

1

Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma.

Li X, Liu Y, Granberg KJ, Wang Q, Moore LM, Ji P, Gumin J, Sulman EP, Calin GA, Haapasalo H, Nykter M, Shmulevich I, Fuller GN, Lang FF, Zhang W. Li X, et al. Among authors: moore lm. Oncogene. 2015 Mar 26;34(13):1619-1628. doi: 10.1038/onc.2014.98. Epub 2014 Apr 21. Oncogene. 2015. PMID: 24747968 Free PMC article.

2

IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas.

Moore LM, Holmes KM, Smith SM, Wu Y, Tchougounova E, Uhrbom L, Sawaya R, Bruner JM, Fuller GN, Zhang W. Moore LM, et al. Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16675-9. doi: 10.1073/pnas.0900807106. Epub 2009 Sep 16. Proc Natl Acad Sci U S A. 2009. PMID: 19805356 Free PMC article.

3

Targeting miR-21 in glioma: a small RNA with big potential.

Moore LM, Zhang W. Moore LM, et al. Expert Opin Ther Targets. 2010 Nov;14(11):1247-57. doi: 10.1517/14728222.2010.527334. Expert Opin Ther Targets. 2010. PMID: 20942748 Review.

4

Oncogene interactions are required for glioma development and progression as revealed by a tissue specific transgenic mouse model.

Moore LM, Holmes KM, Fuller GN, Zhang W. Moore LM, et al. Chin J Cancer. 2011 Mar;30(3):163-72. doi: 10.5732/cjc.010.10572. Chin J Cancer. 2011. PMID: 21352693 Free PMC article. Review.

5

Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB network.

Holmes KM, Annala M, Chua CY, Dunlap SM, Liu Y, Hugen N, Moore LM, Cogdell D, Hu L, Nykter M, Hess K, Fuller GN, Zhang W. Holmes KM, et al. Among authors: moore lm. Proc Natl Acad Sci U S A. 2012 Feb 28;109(9):3475-80. doi: 10.1073/pnas.1120375109. Epub 2012 Feb 15. Proc Natl Acad Sci U S A. 2012. PMID: 22345562 Free PMC article.

6

Transcriptome and small RNA deep sequencing reveals deregulation of miRNA biogenesis in human glioma.

Moore LM, Kivinen V, Liu Y, Annala M, Cogdell D, Liu X, Liu CG, Sawaya R, Yli-Harja O, Shmulevich I, Fuller GN, Zhang W, Nykter M. Moore LM, et al. J Pathol. 2013 Feb;229(3):449-59. doi: 10.1002/path.4109. J Pathol. 2013. PMID: 23007860 Free PMC article.

7

IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma.

Zhang C, Moore LM, Li X, Yung WK, Zhang W. Zhang C, et al. Among authors: moore lm. Neuro Oncol. 2013 Sep;15(9):1114-26. doi: 10.1093/neuonc/not087. Epub 2013 Jul 21. Neuro Oncol. 2013. PMID: 23877318 Free PMC article. Review.

8

MIR-491: CDKN2A tumor suppressor co-pilot.

Moore LM, Zhang W. Moore LM, et al. Oncoscience. 2015 Aug 21;2(10):825-6. doi: 10.18632/oncoscience.201. eCollection 2015. Oncoscience. 2015. PMID: 26682264 Free PMC article. No abstract available.

9

Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status.

Zhou X, Ren Y, Moore L, Mei M, You Y, Xu P, Wang B, Wang G, Jia Z, Pu P, Zhang W, Kang C. Zhou X, et al. Lab Invest. 2010 Feb;90(2):144-55. doi: 10.1038/labinvest.2009.126. Epub 2010 Jan 4. Lab Invest. 2010. PMID: 20048743 Free article.

10

Mouse models for cancer research.

Zhang W, Moore L, Ji P. Zhang W, et al. Chin J Cancer. 2011 Mar;30(3):149-52. doi: 10.5732/cjc.011.10047. Chin J Cancer. 2011. PMID: 21352691 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

57 results

Search Page